INTERLEUKIN-1 RELEASE INHIBITOREN

摘要

alpha -[10-oxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-carboxylic acids, or physiologically-hydrolysable and -acceptable esters or pharmaceutically acceptable salts thereof are useful for effecting monokine inhibition, in particular interleukin-1 release or secretion inhibition, as a therapeutic means other than anti-inflammatory or anti-pyretic means.